RSNA: Fujifilm offers PACS, CR/DR enhancements

Fujifilm Medical Systems (Booth 6238) is featuring products, works in progress and updates from various modalities, including imaging informatics, x-ray, advanced visualization and cardiovascular imaging at the 2009 Radiological Society of North America (RSNA) conference in Chicago next week.

The company said it is extending its Synapse product portfolio with new imaging and information products and features including Synapse 3D, Synapse communications and enhancements for full-field digital mammography (FFDM). Synapse 3D is introducing a 3D product which offers modules delivering both radiology- and cardiovascular-specific applications such as 2D, 3D, 4D, virtual ultrasound, liver analysis, lung analysis, coronary CT/MR analysis and cardiac fusion. Synapse communications is a toolset enabling compliance with industry guidelines. Features include critical results reporting, peer review and embedded task-list management. New FFDM features of Synapse PACS include breast area detection algorithms and automatic zoom-to-fit features.

Synapse 3D requires FDA approval and is not yet available in the United States.

At RSNA, Fujifilm will introduce its new tele-RIS that was designed for the business and management needs of radiology practices. Features include a credentialing tool that matches the study with the appropriate radiologist based on state and specialty. A radiologist’s worklist includes visual reminders based on site level agreements.

A new Fujifilm DR (FDR) system at RSNA 2009 will be the FDR AcSelerate. The FDR has a fully automated table and upright system with a lightweight ergonomic design.

The FDR AcSelerate requires FDA 510(k) approval and is not yet available for sale in the United States.

For CR, Fujifilm will showcase its line of CR imaging systems at RSNA 2009, lead by the FCR Go portable digital x-ray system. New for RSNA, the FCR Go will be offered with colorful designs for pediatric facilities. Also being shown at RSNA will be the company’s newly remodeled multi-plate cassette readers that feature wider viewing angles on the LCD, accentuated drive shelves and a reduction in the total overall weight of the systems, according to the Stamford, Conn.-based company.

At RSNA, Fujifilm will be unveiling Synapse cardiovascular version 4.0.4, a Web-based cardiovascular image and information management solution that features additional third party integrations. Interfaces to Vital Images’ ViTALConnect for advanced 3D/4D analysis, and GE Healthcare’s Muse We, for access to ECGs, are two of the new options. In addition, integrations with GE's EchoPAC for import, storage and viewing of EchoPAC created final reports and with Medis Medical’s QAngio XA for the analysis of the left ventricle and coronary vessels in angiograms are integrated in version 4.0.4. The new version also includes a new GUI toolbar.

Fujifilm also is debuting its new DR-based FFDM system, the Aspire-HD. Already in use in other regions of the world, the Aspire HD employs Direct Optical Switching (DOS) technology and a 50 micron pixel size in a 24 x 30 cm amorphous selenium panel. The Aspire HD comes with Fujifilm’s new AWS-d, a color workstation.

Both the Aspire HD and the AWS-d require FDA approval and are not yet available for sale in the United States.

Fujifilm will introduce the second generation of its CR-based FFDM systems at RSNA 2009. This latest evolution of the Aspire ClearView will provide 50 micron resolution and dual-side detector reading. Enhancements include a lighter weight and wider viewing angle on the LCD and a new workstation, the AWS-c. The AWS-c is a color workstation.

The new ClearView reader and AWS-c require FDA approval and are not yet available for sale in the United States.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.